151 related articles for article (PubMed ID: 11953878)
1. Is there a dose response relationship for clodronate in the treatment of tumour induced hypercalcaemia?
Shah S; Hardy J; Rees E; Ling J; Gwilliam B; Davis C; Broadley K; A'Hern R
Br J Cancer; 2002 Apr; 86(8):1235-7. PubMed ID: 11953878
[TBL] [Abstract][Full Text] [Related]
2. Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases--a prospective randomised placebo-controlled multicentre study.
Rotstein S; Glas U; Eriksson M; Pfeiffer P; Hansen J; Söderqvist J; Bandmann U; Strid S
Eur J Cancer; 1992; 28A(4-5):890-3. PubMed ID: 1388038
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.
O'Rourke NP; McCloskey EV; Vasikaran S; Eyres K; Fern D; Kanis JA
Br J Cancer; 1993 Mar; 67(3):560-3. PubMed ID: 8439504
[TBL] [Abstract][Full Text] [Related]
4. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
[TBL] [Abstract][Full Text] [Related]
5. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Plosker GL; Goa KL
Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
[TBL] [Abstract][Full Text] [Related]
6. Clodronate treatment in patients with malignancy-associated hypercalcemia.
Rastad J; Benson L; Johansson H; Knuutila M; Pettersson B; Wallfelt C; Akerström G; Ljunghall S
Acta Med Scand; 1987; 221(5):489-94. PubMed ID: 2955674
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hypercalcaemia of malignancy with clodronate.
Bonjour JP; Rizzoli R
Bone; 1991; 12 Suppl 1():S19-23. PubMed ID: 1835397
[TBL] [Abstract][Full Text] [Related]
8. Effect of a single infusion of alendronate in malignant hypercalcaemia: dose dependency and comparison with clodronate.
Rizzoli R; Buchs B; Bonjour JP
Int J Cancer; 1992 Mar; 50(5):706-12. PubMed ID: 1531972
[TBL] [Abstract][Full Text] [Related]
9. Severe hypercalcaemia four months after acute oliguric renal failure--successful treatment with intravenous clodronate.
Crowe G; Spedding R; McCance DR; Rankin SJ; Atkinson AB
Ir J Med Sci; 1992 Jun; 161(6):414-6. PubMed ID: 1386845
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of calcitonin and clodronate in hypercalcaemia.
Ljunghall S; Rastad J; Akerström G
Bone; 1987; 8 Suppl 1():S79-83. PubMed ID: 2961359
[TBL] [Abstract][Full Text] [Related]
11. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
[TBL] [Abstract][Full Text] [Related]
12. Treatment of malignant hypercalcaemia with clodronate.
Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
[TBL] [Abstract][Full Text] [Related]
13. Treatment of tumor hypercalcemia with clodronate.
Ziegler R; Scharla SH
Recent Results Cancer Res; 1989; 116():46-53. PubMed ID: 2527400
[TBL] [Abstract][Full Text] [Related]
14. [Monotherapy with clodronate for tumor-induced hypercalcemia].
Harjung H; Fritze D
Dtsch Med Wochenschr; 1990 Jan; 115(2):48-52. PubMed ID: 2136827
[TBL] [Abstract][Full Text] [Related]
15. Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia.
Atula ST; Tähtelä RK; Nevalainen JI; Pylkkänen LH
Acta Oncol; 2003; 42(7):735-40. PubMed ID: 14690159
[TBL] [Abstract][Full Text] [Related]
16. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
[TBL] [Abstract][Full Text] [Related]
17. Treatment with clodronate in patients with hypercalcemia secondary to malignancy.
Lind L; Wengle B; Ljunghall S
Ups J Med Sci; 1987; 92(3):259-63. PubMed ID: 2966487
[TBL] [Abstract][Full Text] [Related]
18. Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumour type.
Body JJ; Dumon JC
Ann Oncol; 1994 Apr; 5(4):359-63. PubMed ID: 8075034
[TBL] [Abstract][Full Text] [Related]
19. Clodronate. A randomized study in the treatment of cancer-related hypercalcemia.
Witte RS; Koeller J; Davis TE; Benson AB; Durie BG; Lipton A; Stock JL; Citrin DL; Jacobs TP
Arch Intern Med; 1987 May; 147(5):937-9. PubMed ID: 2953318
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of tumor hypercalcemia with clodronate. Effect on parathormone and calcitriol].
Scharla SH; Minne HW; Sattar P; Mende U; Blind E; Schmidt-Gayk H; Wüster C; Ho T; Ziegler R
Dtsch Med Wochenschr; 1987 Jul; 112(28-29):1121-5. PubMed ID: 2956079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
